|
|
| Research article summary (published 30 Jul 2009): |
Distinct HIC1-SIRT1-p53 loop deregulation in lung squamous carcinoma and adenocarcinoma patients.
Full Abstract
A HIC1-SIRT1-p53 circular loop in which hypermethylation in cancer 1 (HIC1) represses the transcription of SIRT1 that deacetylates and inactivates p53 thus leading to HIC1 inactivation has been identified in cell and animal models. However, the alteration and prognostic effects of HIC1-SIRT1-p53 circular loop have never been demonstrated in human cancer patients. We examine the HIC1-SIRT1-p53 alterations in 118 lung cancer patients to define their etiological roles in tumorigenesis. We found that patients with lung squamous cell carcinoma with low p53 acetylation and SIRT1 expression mostly showed low HIC1 expression, confirming deregulation of HIC1-SIRT1-p53 circular loop in the clinical model. Interestingly, the expression of deleted in breast cancer 1 (DBC1), which blocks the interaction between SIRT1 deacetylase and p53, led to acetylated p53 in patients with lung adenocarcinoma. However, epigenetic alteration of HIC1 promoter by posttranslational modifications of histones and promoter hypermethylation favoring the compacted chromatin production attenuated the transcriptional induction by acetylated p53. Importantly, lung cancer patients with altered HIC1-SIRT1-p53 circular regulation showed poor prognosis. Our data show the first valid clinical evidence of the deregulation of HIC1-SIRT1-p53 loop in lung tumorigenesis and prognosis. Distinct status of p53 acetylation/deacetylation and HIC1 alteration mechanism result from different SIRT1-DBC1 control and epigenetic alteration in lung squamous cell carcinoma and lung adenocarcinoma.
Author information
Author/s: Tseng, Ruo-Chia (RC); Lee, Chin-Chu (CC); Hsu, Han-Shui (HS); Tzao, Ching (C); Wang, Yi-Ching (YC);
Affiliation: Department of Pharmacology, National Cheng Kung University, Tainan 70101, Taiwan, ROC.
Journal and publication information
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal: Neoplasia (New York, N.Y.) (Neoplasia), published in Canada. (Language: eng)
Reference: 2009-Aug; vol 11 (issue 8) : pp 763-70
Dates: Created 2009/08/03; Completed 2009/10/09;
PMID: 19649206, status: MEDLINE (last retrieved date: 10/9/2009)
Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.
External Links for this article
(including full text providers, if available):
Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.
This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.
MeSH headings (categories)
This article was linked to the MeSH Headings (categories) shown below.
Note: Bold headings indicate primary MeSH headings or qualifiers.
Associated Chemicals: HIC1 protein, human (0) ; Kruppel-Like Transcription Factors (0) ; RNA, Messenger (0) ; Tumor Suppressor Protein p53 (0) ; SIRT1 protein, human (EC 3.5.1.-) ; Sirtuins (EC 3.5.1.-)Related articles
These are the most related articles currently in our database:
- Hepatocyte growth factor is predominantly expressed by the carcinoma cells in non-small-cell lung cancer.
30 Dec 2000 - Differential expression of critical cellular genes in human lung adenocarcinomas and squamous cell carcinomas in comparison to normal lung tissues.
27 Feb 2002 - Identification of a transcriptional profile associated with in vitro invasion in non-small cell lung cancer cell lines.
7 Jul 2004 - Wnt5a expression is associated with the tumor proliferation and the stromal vascular endothelial growth factor--an expression in non-small-cell lung cancer.
29 Nov 2005 - Reduced transcription of the RB2/p130 gene in human lung cancer.
30 Oct 2003 - Detection of K-ras gene mutations in non-neoplastic lung tissue and lung cancers.
13 May 1996 - Higher expression of RhoC is related to invasiveness in non-small cell lung carcinoma.
30 Oct 2003 - Correlation between methylation status of the p16/CDKN2 gene and the expression of p16 and Rb proteins in primary non-small cell lung cancers.
17 Jun 1998 - Methylation discriminators in NSCLC identified by a microarray based approach.
29 Jun 2005 - Mechanisms of p16INK4A inactivation in non small-cell lung cancers.
27 Jan 1998
Related Article Map
Legend:
- FREE Full text Article.
- Abstract only.
- Title only. More help.
See a larger map of 100+ related articles.